Jia Jie Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 11, 2023 at 04:11 am IST
Share
Jia Jie Biomedical Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 87.06 million compared to TWD 69.07 million a year ago. Net loss was TWD 12.83 million compared to TWD 1.45 million a year ago. Basic loss per share from continuing operations was TWD 0.14 compared to TWD 0.02 a year ago. Diluted loss per share from continuing operations was TWD 0.14 compared to TWD 0.02 a year ago.
For the six months, sales was TWD 165.32 million compared to TWD 145.38 million a year ago. Net loss was TWD 35.61 million compared to TWD 3.5 million a year ago. Basic loss per share from continuing operations was TWD 0.4 compared to TWD 0.04 a year ago. Diluted loss per share from continuing operations was TWD 0.4 compared to TWD 0.04 a year ago.
Jia Jie Biomedical Co Ltd is a Taiwan-based company mainly engaged in the processing, production and distribution of turtles and turtle processed products. The Company operates through two business segments. Taiwan Operation segment is engaged in the production and sale of health foods. China Mainland Operation segment is engaged in the production of water purification equipment and related parts. Products are include nutrition and health care series, health water series, home supplies series. Products are mainly sold to Taiwan and mainland China.
JIA JIE BIOMEDICAL CO., LTD. 
